Feb 09, 2026 XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Dec 30, 2025 XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
Feb 9, 2026 • 9:53 AM EST XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
Upcoming Event Mar 11, 2026 • 11:20 am EDT Leerink 2026 Global Healthcare Conference View Event Add to Calendar View All
